CC BY 4.0 · Endoscopy
DOI: 10.1055/a-2563-1606
Original article

Recurrences after piecemeal endoscopic mucosal resection of 10-20mm non-pedunculated colorectal polyps: a multicenter cohort study

1   Gastroenterology and Hepatology, Radboudumc, Nijmegen, Netherlands (Ringgold ID: RIN6034)
,
Yark Hazewinkel
2   Department of Gastroenterology, Tergooi Medical Centre, Hilversum, Netherlands (Ringgold ID: RIN3913)
,
Jochim S. Terhaar sive Droste
3   Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, Netherlands (Ringgold ID: RIN10233)
,
R W.M. Schrauwen
4   Gastroenterology and Hepatology, Bernhoven Hospital Location Uden, Uden, Netherlands (Ringgold ID: RIN97772)
,
Adriaan CITL Tan
5   Gastroenterology & Hepatology, Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands (Ringgold ID: RIN6030)
,
Parweez Koehestanie
6   Department of Gastroenterology and Hepatology, Bravis Hospital, Roosendaal, Netherlands (Ringgold ID: RIN37226)
,
Mariëtte C.A. van Kouwen
1   Gastroenterology and Hepatology, Radboudumc, Nijmegen, Netherlands (Ringgold ID: RIN6034)
,
Peter D. Siersema
7   Dept. of Gastroenterology and Hepatology and Hepatology, Erasmus MC University Medical Center, Rotterdam, Netherlands
1   Gastroenterology and Hepatology, Radboudumc, Nijmegen, Netherlands (Ringgold ID: RIN6034)
› Author Affiliations

Background and study aims: Surveillance guidelines are equivocal on the necessity of early surveillance colonoscopy (ESC) after piecemeal endoscopic mucosal resection (pEMR) of 10-20mm non-pedunculated colorectal polyps (NPCPs). This study aimed to assess recurrence rates and associated factors at ECS following pEMR of 10-20mm NPCPs. Patients and methods: A retrospective, multicenter cohort study was performed at five hospitals in The Netherlands. Patients who underwent pEMR of NPCPs sized 10-20mm between 2014 and 2021 and were referred for ESC (range: 3-9 months) were included. The primary outcome was recurrence rate at ESC. Secondary outcomes included scar identification rates, both overall and of tattooed sites. A mixed-effects model was used to identify associated factors with recurrence. Results: A total of 389 patients with pEMR of 426 NPCPs sized 10-20mm (median: 15mm, interquartile range: 13-20mm) were included. Overall, 262/426(62%; 95% confidence interval (CI): [57-66]) scars were identified at ESC, increasing to 82% of tattooed sites. The overall recurrence rate was 35/426(8.2%; 95%CI [6.0-11.2]), and 35/262(13.4%; 95%CI [9.8-18.0]) when the scar was identified. Median recurrence size was 5mm, without high-grade dysplasia. No NPCP characteristics were associated with recurrence. Conclusions: This real-world study found a substantial recurrence rate at ESC following pEMR of 10-20mm NPCPs. ESC scar identification was moderate but improved with tattoo placement. Although early surveillance could be considered to avoid missing recurrences, the small recurrence size and absence of high-grade dysplasia suggest that modestly extending the interval beyond that of our study may still allow timely detection of recurrences and metachronous lesions.



Publication History

Received: 27 June 2024

Accepted after revision: 14 February 2025

Accepted Manuscript online:
20 March 2025

© . The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany